/

Società

Ch

Non verificato

Chemify

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniIndustriaSalute

6 comunicati stampa

Guarda tutti i comunicati

10/12/2025

Industria

Scienza

Associazioni/Professionisti

Farmaceutica

Tecnica

HIV, AIDS e malattie autoimmuni

Biotecnologia

Finanza

Salute

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

Fonte

Emittente

1.00

0

21/10/2025

Chemify Raises More Than $50 Million in Oversubscribed Series B to Drive Global Expansion of Digital Chemistry and Discovery

Fonte

Emittente

1.00

0

27/02/2025

Former Apple and Intel Executive Michael Bell Joins Chemify as Chief Technology Officer

Fonte

Emittente

1.00

0

10/01/2025

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Fonte

Emittente

1.00

0

01/10/2024

Tecnica

HIV, AIDS e malattie autoimmuni

Chimica

Industria

Biotecnologia

Farmaceutica

Salute

Chemify Receives Grant to Design and Discover New Drug Leads for Tuberculosis and Malaria Using Digital Chemistry Technology

Fonte

Emittente

1.00

0

14/08/2024

Chemify Hires Kevin McGowan as Chief Business Officer to Scale Commercial and Business Growth of Digital Chemistry Technology

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0